Skip to main content
Intended for healthcare professionals
[image]
•  Subscribe
•  Log In More
Log in via Institution
Log in via OpenAthens
Log in via BCS
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username *
Password *
Forgot your log in details?Register a new account?
Forgot your user name or password?
•  Basket
•  Search More
Search for this keyword
Advanced search
[image]
•  Latest content
•  Current issue
•  Archive
•  Browse by collection
•  Authors
•  About
•  Podcasts
Search for this keyword


Advanced search
•  Close More
Main menu
○  Latest content
○  Current issue
○  Archive
○  Browse by collection
○  Authors
○  About
○  Podcasts
•  Subscribe
•  Log in More
Log in via Institution
Log in via OpenAthens
Log in via BCS
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username *
Password *
Forgot your log in details?Register a new account?
Forgot your user name or password?
•  BMJ Journals
You are here
•  Home
•  Archive
•  Volume 93, Issue 1


•  Clinical trials of endothelin antagonists in heart failure:
publication is good for the public health
Email alerts
Article Text
Article menu
•  Article
Text
•  Article
info
•  Citation
Tools
•  Share
•  Rapid Responses
•  Article
metrics
•  Alerts
[image]PDF
Editorials
Clinical trials of endothelin antagonists in heart failure: publication is
good for the public health
1. N F Kelland,
2. D J Webb
1. 
Clinical Pharmacology Unit, Centre for Cardiovascular Science,
University of Edinburgh, Queen’s Medical Research Institute,
Edinburgh, UK
1. Correspondence to:
D J Webb
Clinical Pharmacology Unit, Centre for Cardiovascular
Science, University of Edinburgh, Queen’s Medical Research
Institute, 3rd Floor East Room E3.22, 47 Little France
Crescent, Edinburgh EH16 4TJ, UK; d.j.webb{at}ed.ac.uk


Abstract
The failure of endothelin antagonists to show benefit in heart
failure cannot be understood until all the clinical trials are fully
published
•  CHF, chronic heart failure
•  EARTH, Endothelin A Receptor Antagonist Trial in Heart
Failure
•  HEAT, Haemodynamic and Neurohumoral Effects of Selective
Endothelin A Receptor Blockade in Chronic Heart Failure
•  NYHA, New York Heart Association
https://doi.org/10.1136/hrt.2006.089250
Statistics from Altmetric.com
Request Permissions
If you wish to reuse any or all of this article please use the link
below which will take you to the Copyright Clearance Center’s
RightsLink service. You will be able to get a quick price and instant
permission to reuse the content in many different ways.
•  CHF, chronic heart failure
•  EARTH, Endothelin A Receptor Antagonist Trial in Heart
Failure
•  HEAT, Haemodynamic and Neurohumoral Effects of Selective
Endothelin A Receptor Blockade in Chronic Heart Failure
•  NYHA, New York Heart Association


View Full Text
Read the full text or download the PDF:
Subscribe
Log in 
Log in via Institution


Log in via OpenAthens
Log in via BCS
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username *
Password *
Forgot your log in details?Register a new account?
Forgot your user name or password?
Read the full text or download the PDF:
Subscribe
Log in 


Log in via Institution
Log in via OpenAthens
Log in via BCS
Log in using your username and password


For personal accounts OR managers of institutional accounts
Username *
Password *
Forgot your log in details?Register a new account?
Forgot your user name or password?


•  [image]
•  Content


○  Latest content
○  Current issue
○  Archive
○  Browse by collection
○  Most read articles
○  Top cited articles
○  Responses
•  Journal
○  About
○  Editorial board
○  Sign up for email alerts
○  Subscribe
○  Education in heart
○  Best Research Paper Award
○  Thank you to our reviewers
•  Authors
○  Instructions for authors
○  Submit an article
○  Editorial policies
○  Open Access at BMJ
○  BMJ Author Hub
•  Help
○  Contact us
○  Reprints
○  Permissions
○  Advertising
○  Feedback form
•  RSS
•  Twitter
•  Facebook
•  SoundCloud
•  YouTube


•  Website Terms & Conditions
•  Privacy & Cookies
•  Contact BMJ
Cookie Settings
Online ISSN: 1468-201XPrint ISSN: 1355-6037


Copyright © 2025 BMJ Publishing Group Ltd & British Cardiovascular Society. All
rights, including for text and data mining, AI training, and similar technologies,
are reserved.


